Steinmaus C, Smith AH, Jones RM, Smith
MT. Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases
could mask an important association.Occup. Environ. Med. 65:371-378, 2008. [PDF]
Yuan Y, Marshall G,
Ferreccio C, Steinmaus C, Selvin S, Liaw J, Bates MN, Smith AH. Acute myocardial infarction mortality
in comparison with lung and bladder cancer mortality in arsenic-exposed
Region II of Chile
from 1950 to 2000.Am J Epidemiol. 166:1381-1391, 2007. [PDF]
Marshall G, Ferreccio C,
Yuan Y, Bates MN, Steinmaus C, Selvin S, Liaw J, Smith AH. Fifty-year study of lung and bladder
cancer mortality in Chile
related to arsenic in drinking water.J Natl Cancer Inst
99:920-928, 2007. [PDF]
Smith MT, Jones RM,
Smith AH. Benzene exposure and risk
of non-Hodgkin lymphoma. Cancer
Epidemiol Biomarkers Prev 16:385-91, 2007. [PDF]
Steinmaus C, Moore LE, Shipp M, Kalman D,
Rey OA, Biggs ML, Hopenhayn C, Bates MN, Zheng S, Wiencke JK, Smith AH. Genetic
polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of
arsenic. J Toxicol Environ Health A 70:159-70, 2007. [PDF]
von Ehrenstein OS, Poddar S, Yuan Y, Guha Mazumder
DN, Eskenazi B, Basu A, Hira-Smith
M, Ghosh N, Lahiri S, Haque R, Ghosh A,
Kalman D, Das S, Smith AH.. Children’s intellectual
function in relation to arsenic exposure. Epidemiology
18:44-51, 2007. [PDF]
Hira-Smith MM, Yuan Y,Savarimuthu
X, Liaw J, Hira A, Green C, Hore T, Chakraborty P, von Ehrenstein OS,
Smith AH. Arsenic concentrations and bacterial contamination in a pilot
shallow dugwell program in West Bengal, India. J Environ Sci Health
A 42: 89-95, 2007. [PDF]
Savarimuthu X,
Hira-Smith MM, Yuan Y, von Ehrenstein OS,DasS, Ghosh N, Guha Mazumder DN, Smith AH. Seasonal variation of arsenic concentration in tube wells in West
Bengal, India. J Health Popul
Nutr 24:277-281, 2006. [PDF]
von Ehrenstein OS, Jenny A, Basu A, Smith
KR, Hira-Smith M, Smith AH. Capacity building in environmental health
research in India and Nepal. Int J Occup Environ Health12:300-6,
2006. [PDF]
Steinmaus CM, George CM, Kalman DA, Smith AH. The evaluation of two new arsenic field
test kits capable of detecting arsenic water concentrations close to 10 mg/l. Environ Sci Technology40:3362-6, 2006. [PDF]
SmithAH, MarshallG, YuanY, FerreccioC, LiawJ, von EhrensteinOS, Steinmaus1, BatesMN,
and SelvinS. Increased mortality from lung cancer
and bronchiectasis in young adults following exposure to arsenic in utero and early childhood. Environ Health Perspect 114:1293-96,
2006. [PDF]
Steinmaus
C, Bates MN, Yuan Y, Kalman D, Atallah R, Rey O, Biggs ML, Hopenhayn C,
Moore L, Hoang B, Smith AH. Arsenic methylation and bladder cancer
risk in case-control studies in Argentina
and the United States. J Occup Environ Med. 48:478-88, 2006. [PDF]
Mazumder DNG, Steinmaus
C, Bhattacharya P, von Ehrenstein O, Ghosh N, Gotway M, Sil A, Balmes JR,
Haque R, Hira-Smith MM, Smith AH. Bronchiectasis
in persons with skin lesions resulting from arsenic in drinking water.Epidemiology. 2005 Nov; 16(6);760-5. [PDF]
Steinmaus CM, Yuan Y,
Smith AH. The temporal stability of arsenic
concentrations in well water in western Nevada.Environ
Res. 2005 Oct; 99(2):164-8. [PDF]
Steinmaus C, Carrigan K,
Kalman D, Atallah R, Yuan Y, Smith AH. Dietary
intake and arsenic methylation in a U.S. population.Environ Health Perspect. 2005 Sep; 113(9):1153-9.
[PDF]
von Ehrenstein OS, Guha
Mazumder DN ,Yuan Y, Samanta S, Balmes J, Sil A, Ghosh N, Hira-Smith M,
Haque R, Purushothamam R, Lahiri S, Das S, Smith AH.
Decrements in lung function related to arsenic in drinking water in West
Bengal, India.
Am J Epidemiol.. 2005
Sep;162(6):533-41. [PDF]
Steinmaus C, Yuan Y,
Kalman D, Atallah R, Smith AH. Intraindividual
variability in arsenic methylation in a U.S. population.Cancer Epidemiol Biomarkers Prev. 2005
Apr;14(4):919-24. [PDF]
Mitra SR, Mazumder DN,
Basu A, Block G, Haque R, Samanta S, Ghosh N, Smith MM, von Ehrenstein OS,
Smith AH. Nutritional factors and susceptibility to
arsenic-caused skin lesions in West Bengal,
India.Environ Health Perspect. 2004
Jul;112(10):1104-9. [PDF]
Zhuo H, Smith AH and
Steinmaus CM. Selenium and lung cancer: a
quantitative analysis of heterogeneity in the current epidemiological
literature.Cancer Epidemiol Biomarkers
Prev 2004 13:771-8. [PDF]
Steinmaus CM, Lu M, Todd
RL, Smith AH. Probability estimates for the unique
childhood leukemia cluster in Fallon, Nevada, and risks near other U.S.
military aviation facilities.Environ
Health Perspect 2004 112:766-71. [PDF]
Smith AH and Smith MM. Arsenic drinking water regulations in developing countries
with extensive exposure.Toxicology
2004 May 20; 198(1-3):39-44. [PDF]
Moore
LE, Wiencke JK, BatesMN, Zheng S, Rey OA, Smith AH. Investigation of genetic polymorphisms and smoking in a
bladder cancer case-control study in Argentina.Cancer Lett 2004 Aug 10; 211(2): 199-207. [PDF]
Bates MN, Rey OA, Biggs
ML, Hopenhayn C, Moore
LE, Kalman D, Steinmaus C, Smith AH. Case-control
study of bladder cancer and exposure to arsenic in Argentina.Am J Epidemiol 2004 Feb 15; 159(4): 381-9. [PDF]
Bates MN, Buckland SJ,
Garrett N, Ellis H, Needham
LL, Patterson DG, Turner WE, Russel DG. Persistent
organochlorines in the serum of the non-occupationally exposed New Zealand
population.Chemosphere 2004 Mar;
54(10): 1431-43. [PDF]
Steinmaus C, Yuan Y, BatesMN,
Smith AH. Case-control study of bladder cancer and
drinking water arsenic in Western United States.Am J Epidemiol 2003 Dec 15; 158(12):
1193-1201. [PDF]
Smith MM, Hore T,
Chakraborty P, Chakraborty DK, Savarimuthu X, Smith AH. A dugwell program to provide arsenic-safe water in West
Bengal, India:
preliminary results.J Environ Sci Health
Part A Tox Hazard Subst Environ Eng. 2003 Jan;38(1):289-99. [PDF]
Moore LE, Smith AH, Eng
C, Sandy D, Kalman D, Bhargava V, Chew K, Ferreccio C, Rey OA, Hopenhayn
C, Biggs ML, Bates MN, Waldman FM. P53 Alterations
in bladder tumors from arsenic and tobacco exposed patients.Carcinogenesis. 2003 Nov;24(11):1785-1791. [PDF]
Haque R, Mazumder DN,
Samanta S, Ghosh N, Kalman D, Smith MM, Mitra S, Santra A, Lahiri S, Das
S, De BK, Smith AH. Arsenic in drinking water and
skin lesions: dose-response data from West Bengal, India.Epidemiology. 2003 Mar;14(2):174-82. [PDF]
ClaudioL.Building self-reliance in environmental science: the ITREOH
experience.Epidemiology. 2003
Jul;111(9):A460-32. [PDF]
Smith AH, Lopipero PA, BatesMN,
Steinmaus C. Public health. Arsenic epidemiology and
drinking water standards.Science.
2002 Jun 21;296(5576):2145-6. [PDF]
Moore LE, Lu M, Smith AH
Childhood cancer incidence and arsenic exposure in
drinking water in Nevada.Arch Environ Health. 2002
May-Jun;57(3):201-6. [PDF]
Moore LE, Smith AH, Eng
C, Kalman D, DeVries S, Bhargava V, Chew K, Moore D 2nd, Ferreccio C, Rey
OA, Waldman FM. Arsenic-related chromosomal
alterations in bladder cancer.J Natl
Cancer Inst. 2002 Nov;94(22):1688-96. [PDF]
Chung JS, Kalman DA,
Moore LE, Kosnett MJ, Arroyo AP, Beeris M, Mazumder DN, Hernandez AL, Smith AH. Family correlations of arsenic methylation patterns in
children and parents exposed to high concentrations of arsenic in drinking
water.Environ Health Perspect. 2002
Jul;110(7):729-33. [PDF]
Bates MN, Selevan SG,
Ellerbee SM, Gartner LM Reporting needs for studies
of environmental chemicals in human milk.J
Toxicol Environ Health A. 2002 Nov 22;65(22):1867-79. [PDF]
Smith AH, Lopipero P. Invited commentary: how do the Seveso findings affect
conclusions concerning TCDD as a human carcinogen?Am J Epidemiol. 2001 Jun 1;153(11):1045-7,1048-9.
[PDF]
Moore L, Wiencke J, Eng C, Zheng S,
Smith AH. Evaluation of buccal cell collection
protocols for genetic susceptibility studies.Biomarkers, 6: 448-54, 2001. [PDF]
Steinmaus, C, Nuñez S,
Smith AH. Diet and bladder cancer: a meta-analysis
of six dietary variables.Am J Epidemiol.
2000 Apr 1;151(7):693-702. [PDF]
Steinmaus C, Moore LE,
Hopenhayn-Rich C, Biggs ML, Smith AH. Arsenic in
drinking water and bladder cancer.Cancer
Invest. 2000 Feb;18(2):174-82. [PDF]
Smith AH, Arroyo AP,
Guha Mazumder DN, Kosnett MJ, Hernandez AL, Beeris M, Smith T, Moore LE. Arsenic-induced skin lesions among Atacameño people in
northern Chile
despite good nutrition and centuries of exposure.Environ Health Perspect. 2000 Jul;108(7):617-20.
[PDF]
Smith AH, Lingas EO,
Rahman M. Contamination of drinking-water by arsenic
in Bangladesh:
a public health emergency.Bull World
Health Organ. 2000 Sept;78(9):1093-103. [PDF]
Smith AH, Steinmaus CM. Arsenic in urine and drinking water [letter]Environ Health Perspect. 2000 Nov;108(11):A494-5.
[PDF]
Moore LE, Godfrey T, Eng
C, Smith AH, Ho R, Waldman FM. Validation of
flourescent SSCP analysis for sensitive detection of p53 mutations.Biotechniques. 2000 28:986-92. [PDF]
Guha Mazumder DN, Haque
R, Ghosh N, De BK, Santra A, Chakraborti D, Smith AH. Arsenic in drinking water and the prevalence of
respiratory effects in West Bengal,
India.Int J Epidemiol. 2000 Dec;29(6):1047-52.
[PDF]
Ferreccio C, González C,
Milosavjlevic V, Marshall G, Sancha AM, Smith AH. Lung
cancer and arsenic concentrations in drinking water in Chile.Epidemiology. 2000 Nov;11(6):673-9. [PDF]
Smith AH, Biggs ML,
Moore LE, Haque R, Steinmaus C, Chung J, Hernandez AL, Lopipero P. Cancer risks from arsenic in drinking water: implications
for drinking water standards. In: W Chappell, CO Abernathy and RL
Calderon (eds.): Arsenic esposure and health
effects: proceedings of the Third International Conference on Arsenic
Exposure and Health Effects, July 12-15, 1998, San Diego, California.
Oxford:
Elsevier Science, Ltd., pp.191-99, 1999. [PDF]
Smith AH. Amphibole fibers, chrysotile fibers, and pleural
mesothelioma.Am J Ind Med. 1998 33:96. [PDF]
Smith AH, Goycolea M,
Haque R, Biggs ML. Marked increase in bladder and
lung cancer mortality in a region of Northern Chile
due to arsenic in drinking water.Am J
Epidemiol. 1998 Apr 1;147(7):660-9. [PDF]
NIEHSCenter
for Environmental Health Sciences. Newsletter:
International environmental health research.NIEHS Newsletter. 1998 Spring:1-3. [PDF]
Hopenhayn-Rich C, Biggs
ML, Smith AH. Lung and kidney cancer mortality
associated with arsenic in drinking water in Cordoba, Argentina.Int J Epidemiol. 1998 Aug;27(4):561-9.
[PDF]
Guha Mazumder DN, Haque
R, Ghosh N, De BK, Santra A, Chakraborti D Smith AH. Arsenic levels in drinking water and the prevalence of
skin lesions in West Bengal, India.Int J Epidemiol. 1998 Oct;27(5):871-7. [PDF]
Biggs ML, Haque R, Moore
L, Smith AH. Arsenic-laced water in Chile [letter;
comment]Science. 1998 Aug
7;281(5378):785. [HTML]
Bhatia R, Lopipero P,
Smith AH. Diesel exhaust exposure and lung cancer.Epidemiology. 1998 Jan;9(1):84-91. [summary]
Smith AH. Technical Report.Assignment
Report, WHO Project BAN CWS 001 June 1998. [PDF]
Smith AH. Technical Report And Review Of Action Plan For Arsenic In
Drinking Water In Bangladesh Focusing On HealthAssignment Report, WHO Project BAN CWS 001/D
February 1998. [PDF]
Smith AH. Report and Action Plan for Arsenic in Drinking Water
Focusing on Health, Bangladesh.Assignment Report, WHO Project BAN CWS 001 March
1997. [PDF]
Wright C, Lopipero P,
Smith AH. Meta-analysis and Risk Assessment.
In: Topics in Environmental Epidemiology
Eds. Steenland K and Savitz DA: OxfordUniversity Press,
1996. [PDF]
Moore, LE, Smith AH, Hopenhayn-Rich C,
Biggs ML, Kalman DA, Smith MT. Decrease in bladder
cell micronucleus prevalence after intervention to lower the concentration
of arsenic in drinking water.Cancer
Epidemiol Biomarkers & Prev. 1997 Dec;6(12):1051-6. [PDF]
Moore LE, Smith AH,
Hopenhayn-Rich C, Biggs ML, Kalman DA, Smith MT. Micronuclei
in exfoliated bladder cells among individuals chronically exposed to
arsenic in drinking water.Cancer Epidemiol
Biomarkers & Prev. 1997 Jan;6(1):31-6. [PDF]
Biggs ML, Kalman DA,
Moore LE, Hopenhayn-Rich C, SmithMT, Smith AH. Relationship of urinary arsenic to intake estimates and a
biomarker of effect, bladder cell micronuclei.Mutat Res. 1997 Jun;386(3):185-95. [PDF]
Aposhian HV, Arroyo A,
Cebrian M, Del Razo LM, Hurlbut KM, Dart RC, Gonzalez-Ramirez D, Kreppel
H, Speiske H, Smith AH, Gonsebatt ME, Ostrosky-Wegman P, Aposhian MM. DMPS-Arsenic Challenge Test: I-Increased Urinary Excretion
of Monomethylarsonic Acid in Humans Given Dimercaptopropane Sulfonate.J Pharmacol Exp Ther. 1997
Jul;282(1):192-200. [PDF]
Smith AH, Sciortino S,
Goeden H, Wright CC. Consideration of background
exposures in the management of hazardous waste sites: a new approach to
risk assessment.Risk Anal. 1996
Oct;16(5): 619-25. [PDF]
Smith AH, Wright CC. Chrysotile asbestos is the main cause of pleural
mesothelioma.Am J Ind Med. 1996 Sep;30(3): 252-66.
[PDF]
Moore L, Warner ML,
Smith AH, Kalman D, Smith MT. Use of the fluorescent
micronucleus assay to detect the genotoxic effects of radiation and
arsenic in human exfoliated epithelial cells.Environ Mol Mutagen. 1996;27(3):176-84. [PDF]
Mendel MJ, Fisk WJ,
Deddens JA, Seavey WG, Smith AH, Smith DF, Hodgson AT, Daisey JM, Goldman
LR. Elevated symptom prevalence associated with
ventilation type in office buildings.Epidemiology.
1996 Nov; 7:(6) 583-9. [PDF]
Hopenhayn-Rich C, Biggs
ML, Smith AH, Kalman D, Moore LE. Methlyation study
in a population environmentally exposed to high arsenic water.Environ Health Perspect. 1996 Jun;104(6):620-8.
[HTML]
Hopenhayn-Rich C, Biggs
ML, Kalman D, Moore
LE, Smith AH. Arsenic methylation patterns before
and after changing from higher to lower concentrations of arsenic in
drinking water.Environ Health Perspect.
1996 Nov;104(11):1200-7. [HTML]
Hopenhayn-Rich C, Biggs
ML, Fuchs A, Bergoglio R, Tello E, Nicolli H, Smith AH. Bladder cancer mortality associated with arsenic in
drinking water in Argentina.Epidemiology. 1996 Mar;7(2):117-24. [PDF]
Holly EA, Aston DA, Ahn
DK, Smith AH. Intraocular melanoma linked to
occupations and chemical exposures.Epidemiology.
1996 Jan;7(1):55-61. [summary]
Brown KG, Beck BD. Arsenic and bladder cancer mortality.Epidemiology. 1996 Sep;7(5):557-8. [PDF]
Smith AH. Epidemiology: bias bias everywhere? and not a drop of
science? In: Graham JD (ed) The Role of
Epidemiology in Regulatory Risk Assessment. Elsevier Science: Boston 1995 39-43.
Smith AH, Wright C. Environmental risk assessment using epidemiologic data.
In: Host Factors in Environmental Epidemiology,Cracow,
Central and Eastern European Chapter, ISEE/ISEA, 1995, 9-25.
Smith AH, Hopenhayn-Rich
C, Biggs ML, Kalman D. Re: Arsenic risk assessment.
[letter; comment].Environ Health Perspect.
1995 Jan;103(1):13-7. [PDF]
Smith AH, Lopipero PA, Barroga VR. Meta-analysis of studies of lung cancer among silicotics.Epidemiology. 1995 Nov;6(6):617-24. [summary]
Moore L, Smith AH,
Hopenhayn-Rich C, Biggs ML, Warner ML, Kalman D, Smith MT. Increased bladder cell micronuclei found in two
populations environmentally exposed to arsenic in drinking water.Clin Chem. Dec 1995 41(12): 1915-7. [summary]
Bates MN, Smith AH,
Cantor KP. Case-control study of bladder cancer and
arsenic in drinking water.Am J Epidemiol.
1995 Mar 15;141(6):523-30. [summary]
Warner M, Moore L, SmithMT,
Kalman D, Fanning E, Smith AH. Increased micronuclei
in exfoliated bladder cells of persons who chronically ingest arsenic
contaminated water in Nevada.Cancer Epidemiol Biomarkers & Prev.
1994 Oct-Nov;3(7):583-90. [summary]
Smith AH, Hopenhayn-Rich
C, Biggs ML, Moore L, Dale J, Warner M, Bates M, Engel R. Epidemiological study designs to address potential high
bladder cancer risks from arsenic in drinking water. In: Chappell
WR, Abernathy CO, Cothern CR (eds): Arsenic:
Exposure and Health Northwood: Science and Technology Letters:
109-17, 1994. [summary]
Smith AH, Duggan HM,
Wright C. Assessment of cancer clusters using
limited cohort data with spreadsheets: application to a leukemia cluster
among rubber workers.Am J Ind Med.
1994;25(6):813-23. [summary]
Engel RR, Hopenhayn-Rich
C, Receveur O, Smith AH. Vascular effects of chronic
arsenic exposure: a review.Epidemiol Rev.
1994;16(2):184-209. [summary]
Engel RR, Smith AH. Arsenic in drinking water and mortality from vascular
disease: an ecologic analysis in 30 U.S. counties.Arch Environ Health. 1994 Sep-Oct;49(5):418-27. [summary]
Waller DK, Lustig LS, Smith
AH, Hook EB. Alpha-fetoprotein: a biomarker for
pregnancy outcome.Epidemiology.
1993 Sep;4(5):471-6. [summary]
Smith AH, Hopenhayn-Rich
C, Warner M, Biggs ML, Moore L, Smith MT. Rationale
for selecting exfoliated bladder cells micronuclei as potential biomarkers
for arsenic genotoxicity.J Toxicol Environ
Health. 1993 Oct-Nov;40(2-3):223-34. [summary]
Hertz-Picciotto I, Smith
AH. Observations on the dose-response curve for arsenic
exposure and lung cancer.Scand J Work
Environ Health. 1993 Aug;19(4):217-26. [summary]
Hopenhayn-Rich C, Smith
AH, Goeden H. Human studies do not support the
methylation threshold hypothesis for the toxicity of inorganic arsenic.Environ Res. 1993 Feb;60(2):161-77. [summary]
Engel RR, Receveru O. Re: "Arsenic ingestion and internal cancers: a
review".Am J Epidemiol. 1993
Nov 15;138(10):896-7. [PDF]
Smith AH, Bates MN. Confidence limit analyses should replace power
calculations in the interpretation of epidemiologic studies.Epidemiology. 1992 Sep;3(5):449-52. [summary]
Smith AH, Hopenhayn-Rich
C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Smith T, and
Kosnett MJ. Cancer risks from arsenic in drinking
water.Environ Health Perspect. 1992
Jul;97:259-67. [PDF]
Hertz-Picciotto I, Smith
AH, Holzman D, Lipsett M, Alexeef G. Synergism
between occupational arsenic exposure and smoking in the induction of lung
cancer.Epidemiology. 1992
Jan;3(1):23-31. [summary]
Smith AH, Patterson DG,
Jr., Warner ML, MacKenzie R, Needham LL. Serum
2,3,7,8-tetrachlorodibenzo-p-dioxin levels of New Zealand pesticide
applicators and their implication for cancer hypotheses.J Natl Cancer Inst. 1992 Jan 15;84(2):104-8.
[Summary]
Bates MN, Smith AH,
Hopenhayn-Rich C. Arsenic ingestion and internal
cancers: a review.Am J Epidemiol.
1992 Mar 1;135(5):462-76. [PDF]
Smith AH, Waller KD. Serum beta-carotene in persons with cancer and their
immediate families.Am J Epidemiol.
1991 Apr 1;133(7):661-71. [summary]
Smith AH, Goeden H. Health risk assessment of incinerator air emissions incorporating
background ambient air data.Combust Sci
Tech. 1990 74:51-61. [summary]
Smith AH, Handley MA,
Wood R. Epidemiological evidence indicates asbestos
causes laryngeal cancer.J Occup Med.
1990 Jun;32(6):499-507. [summary]
Sharp DS, Benowitz NL,
Osterloh JD, Becker CE, Smith AH, Syme SL. Influence
of race, tobacco use, and caffeine use on the relation between blood
pressure and blood lead concentration.Am J
Epidemiol. 1990 May 131(5):845-54. [summary]
Mendell MJ, Smith AH. Consistent pattern of elevated symptoms in air-conditioned
office buildings: a reanalysis of epidemiologic studies.Am J Public Health. 1990 80:1193-9. [summary]
Smith AH, Goeden H,
Frisch J. The importance of the hazard
identification phase of health risk assessments illustrated with antimony
emissions from waste incineration facilities.In: Advances in Risk Analysis, vol 7 (Bonin JJ, StevensonDE,
eds). New York:
Plenum Press, 1989; 539-43. [summary]
Smith AH, Bates MN. Epidemiological studies of cancer and pesticide exposure.
In: 196th National Meeting of the American
Chemical Society,Los Angeles,
CA September 25-30
1989;207-22. [summary]
Smith AH, Shearn VI,
Wood R. Asbestos and kidney cancer: the evidence
supports a causal association.Am J Ind Med.
1989 16(2):159-66. [summary]
Sharp DS, Osterloh J,
Becker CE, Smith AH, Holman BL, Fisher JM. Elevated
blood pressures in treated hypertensives with low-level lead accumulation.Arch Environ Health. 1989 44:18-22. [summary]
Goeden HM, Smith AH. A method for estimation of fish contamination from dioxins
and furans emitted by resource recovery facilities In: JJ Bonin, DE
Stevenson, (eds): Advances in Risk Analysis,
vol 7; New York:
Plenum Press, 1989. [summary]
Goeden HM, Smith AH. Estimation of human exposure from fish contaminated with
dioxins and furans emitted by a resource-recovery facility.Risk Anal. 1989 9:377-83. [summary]
Smith AH. Epidemiologic input to environmental risk assessment.Arch Environ Health, 1988 Mar-Apr
43(2):124-9. [summary]
Frost F, Harter L,
Milham S, Royce R, Smith AH, Hartley J, Enterline P. Lung cancer among women residing close to an arsenic-emitting
copper smelter.Arch Environ Health.
1987 May-Jun;42(3):148-52. [summary]
University of California,
Berkeley ~ School of Public Health ~ 50 University Hall MC7360 ~ Berkeley, CA94720-7360